Predict your next investment

Venture Capital
fh-partners.com

See what CB Insights has to offer

Investments

41

Portfolio Exits

8

Funds

4

About Fountain Healthcare Partners

Headquartered in Dublin, Fountain Healthcare Partners is Ireland's largest dedicated life science venture capital fund. A spin-out investment team from Elan Corporation's corporate venture capital group, Fountain launched its inaugural fund in 2008. Fountainl invests the majority of its capital in Europe with a primary focus on Ireland. Specific areas of interest to Fountain are specialty pharmaceuticals, biotechnology, medical devices and diagnostics.

Fountain Healthcare Partners Headquarter Location

Guild House, 4th Floor Guild Street

Dublin, 1,

Ireland

+353 1 5225100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Fountain Healthcare Partners News

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Jul 20, 2022

Medical Microinstruments, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, RA Capital Management and Biostar Capital, as well as existing investors, Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech. The company also announced the addition of three new members to its board of directors. In addition, the company announced its corporate redomicile from Italy to the United States. The recently opened  Center of Excellence  facility in Pisa, Italy, with 96 employees will continue to be the hub of the company’s research and development, manufacturing, and other business activities. Proceeds from this financing round and the company’s planned U.S. presence seek to launch MMI into its next stage of growth as it seeks to improve the quality of patient care by pushing the boundaries of microsurgery. The company also seeks to expand indications and support ongoing commercialization efforts for the Symani Surgical System in Europe where it received CE mark in 2019. The Symani System was developed specifically to address the challenges of microsurgery and offers NanoWrist Instruments designed to improve a surgeon’s ability to access and suture small, delicate anatomy. “This financing round, coupled with our commitment to access the U.S. market and the addition of visionary leaders to our board, is an exciting moment for the surgical robotics space,” says Mark Toland, CEO of MMI. “We’re pleased to have bridged the Atlantic with premier U.S. life science investors, and existing European investors, who share our same vision of bringing microsurgical robotics to the world.” The Symani Surgical System is designed to improve a surgeon’s ability to repair anatomical structures such as veins, arteries, nerves and lymphatic vessels as small as 0.3 mm in diameter. The platform provides motion scaling and tremor reduction to allow precise micro-movements. Its NanoWrist technology is the world’s smallest wristed instrumentation and is intended to improve a surgeon’s natural dexterity and range of motion beyond the capability of the human hand. Share:

Fountain Healthcare Partners Investments

41 Investments

Fountain Healthcare Partners has made 41 investments. Their latest investment was in Medical Micro Instruments as part of their Series B on July 7, 2022.

CBI Logo

Fountain Healthcare Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/20/2022

Series B

Medical Micro Instruments

$75M

No

4

6/30/2022

Series A - II

Ermium Therapeutics

$6.29M

Yes

2

5/17/2022

Series D

Vivasure Medical

$23M

No

3

9/9/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

7/7/2021

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/20/2022

6/30/2022

5/17/2022

9/9/2021

7/7/2021

Round

Series B

Series A - II

Series D

Series A - II

Series B - II

Company

Medical Micro Instruments

Ermium Therapeutics

Vivasure Medical

Subscribe to see more

Subscribe to see more

Amount

$75M

$6.29M

$23M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

2

3

10

10

Fountain Healthcare Partners Portfolio Exits

8 Portfolio Exits

Fountain Healthcare Partners has 8 portfolio exits. Their latest portfolio exit was Syndesi Therapeutics on March 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/1/2022

Acquired

$99M

5

9/21/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/11/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/7/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/1/2022

9/21/2020

8/11/2020

4/10/2017

3/7/2016

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Fountain Healthcare Partners Fund History

4 Fund Histories

Fountain Healthcare Partners has 4 funds, including Fountain Healthcare Partners Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/3/2020

Fountain Healthcare Partners Fund III

$146.29M

2

12/31/2015

Fountain Healthcare Partners Fund II

Subscribe to see more

Subscribe to see more

$99M

10

1/9/2015

Fountain Healthcare Partners II

$99M

10

3/1/2008

Fountain Healthcare Partners I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

11/3/2020

12/31/2015

1/9/2015

3/1/2008

Fund

Fountain Healthcare Partners Fund III

Fountain Healthcare Partners Fund II

Fountain Healthcare Partners II

Fountain Healthcare Partners I

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$146.29M

$99M

$99M

$99M

Sources

2

10

10

10

Fountain Healthcare Partners Team

3 Team Members

Fountain Healthcare Partners has 3 team members, including current Founder, Managing Partner, Aidan King.

Name

Work History

Title

Status

Aidan King

Founder, Managing Partner

Current

Manus Rogan

Founder, Managing Partner

Current

Justin Lynch

Chief Financial Officer

Current

Name

Aidan King

Manus Rogan

Justin Lynch

Work History

Title

Founder, Managing Partner

Founder, Managing Partner

Chief Financial Officer

Status

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.